BB Biotech Stock Forward View - Simple Regression

BION Stock  CHF 45.30  -1.40  -3.00%   
BB Biotech's Simple Regression reference data is presented on this page, derived from the application of the forecasting model to historical closing prices. Projected values and accuracy measures are included for reference.
The Simple Regression forecasted value of BB Biotech AG on the next trading day is expected to be 46.16 with a mean absolute deviation of 0.97 and the sum of the absolute errors of 60.31.In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as BB Biotech AG historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data. The Simple Regression reference information for BB Biotech is based on available price data and is intended for informational purposes.
Simple Regression model is a single variable regression model that attempts to put a straight line through BB Biotech price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Simple Regression Price Forecast For the 20th of March

Given 90 days horizon, the Simple Regression forecasted value of BB Biotech AG on the next trading day is expected to be 46.16 with a mean absolute deviation of 0.97 , mean absolute percentage error of 1.50 , and the sum of the absolute errors of 60.31 .
Please note that although there have been many attempts to predict BION Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BB Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Stock Forecast Pattern

Backtest BB Biotech  BB Biotech Price Prediction  Research Analysis  

Forecasted Value

For the next trading day, Macroaxis evaluates BB Biotech's predictive range by looking for statistically meaningful downside and upside boundaries. The projected forecast band currently runs from roughly 44.33 on the downside to about 48.00 on the upside.
Market Value
45.30
46.16
Expected Value
48.00
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of BB Biotech stock data series using in forecasting. Note that when a statistical model is used to represent BB Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria120.3569
BiasArithmetic mean of the errors None
MADMean absolute deviation0.9728
MAPEMean absolute percentage error0.0209
SAESum of the absolute errors60.3138
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as BB Biotech AG historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Other Forecasting Options for BB Biotech

For any investor considering BION, BB Biotech's price movement is the central factor in determining investment viability. The noise present in BION Stock price charts can distort investment decisions if not properly addressed.

BB Biotech Related Equities

The following equities are related to BB Biotech within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing BB Biotech against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
 Risk & Return  Correlation

BB Biotech Market Strength Events

Market strength indicators for BB Biotech stock help investors evaluate the security's behavior relative to ongoing market conditions. These tools support better market timing and help identify entry and exit signals for BB Biotech AG.

BB Biotech Risk Indicators

The analysis of BB Biotech's basic risk indicators is a key input for accurate price forecasting and sound investment decisions. Understanding the risk in BB Biotech's investment allows investors to make informed choices about accepting or mitigating that exposure.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for BB Biotech

The amount of media and story coverage tied to BB Biotech AG can signal where market attention is concentrating at the moment. A disciplined read of coverage helps investors separate durable relevance from temporary noise.

Other Macroaxis Stories

Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.

BB Biotech Short Properties

Reviewing short-oriented indicators for BB Biotech AG is useful because long and short participants often create very different signals for timing and volatility. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
Common Stock Shares Outstanding55.1 M
Cash And Short Term Investments99.4 M

Additional Tools for BION Stock Analysis

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Holdings
Check your current holdings and cash position to determine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum